scholarly journals New G-protein-coupled receptor structures provide insights into the recognition of CXCL12 and HIV-1 gp120 by CXCR4

2011 ◽  
Vol 43 (5) ◽  
pp. 337-338 ◽  
Author(s):  
C. Zhong ◽  
J. Ding
2005 ◽  
Vol 280 (35) ◽  
pp. 30924-30934 ◽  
Author(s):  
Atsushi Jinno-Oue ◽  
Nobuaki Shimizu ◽  
Yasushi Soda ◽  
Atsushi Tanaka ◽  
Takahiro Ohtsuki ◽  
...  

2020 ◽  
Vol 16 (2) ◽  
pp. e1008307 ◽  
Author(s):  
Raymond W. Wong ◽  
Ahalya Balachandran ◽  
Peter K. Cheung ◽  
Ran Cheng ◽  
Qun Pan ◽  
...  

1999 ◽  
Vol 73 (6) ◽  
pp. 5231-5239 ◽  
Author(s):  
Nobuaki Shimizu ◽  
Yasushi Soda ◽  
Katsuaki Kanbe ◽  
Hui-Yu Liu ◽  
Atsushi Jinno ◽  
...  

ABSTRACT Twelve G protein-coupled receptors, including chemokine receptors, act as coreceptors and determinants for the cell tropisms of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIV). We isolated HIV-1 variants from T-cell-line (T)- and macrophage (M)-tropic (i.e., dualtropic) (R5-R3-X4) HIV-1 strains and also produced six HIV-1 mutants carrying single-point amino acid substitutions at the tip of the V3 region of the Env protein of HIV-1. These variants and three mutants infected brain-derived CD4-positive cells that are resistant to M-, T-, or dualtropic (R5, X4, or R5-X4) HIV-1 strains. However, a factor that determines this cell tropism has not been identified. This study shows that primary brain-derived fibroblast-like cell strains, BT-3 and BT-20/N, as well as a CD4-transduced glioma cell line, U87/CD4, which were susceptible to these HIV-1 variants and mutants and the HIV-2ROD strain, expressed mRNA of an orphan G protein-coupled receptor (GPCR), GPR1. When a CD4-positive cell line which was strictly resistant to infection with diverse HIV-1 and HIV-2 strains was transduced with GPR1, the cell line became susceptible to these HIV-1 variants and mutants and to an HIV-2 strain but not to T- or dualtropic HIV-1 strains, and numerous syncytia formed after infection. These results indicate that GPR1 functions as a coreceptor for the HIV-1 variants and mutants and for the HIV-2ROD strain in vitro.


Science ◽  
1996 ◽  
Vol 272 (5263) ◽  
pp. 872-877 ◽  
Author(s):  
Y. Feng ◽  
C. C. Broder ◽  
P. E. Kennedy ◽  
E. A. Berger

2020 ◽  
Author(s):  
Manuel Hayn ◽  
Andrea Blötz ◽  
Armando Rodríguez ◽  
Solange Vidal ◽  
Nico Preising ◽  
...  

SUMMARYGPR15 is a G protein-coupled receptor proposed to play a role in mucosal immunity that also serves as entry cofactor for HIV and SIV. To discover novel endogenous GPR15 ligands, we screened a hemofiltrate-derived peptide library for inhibitors of GPR15-mediated SIV infection. Our approach identified a C-terminal fragment of Cystatin C (CysC95-146) that specifically inhibits GPR15-dependent HIV-1, HIV-2 and SIV infection. In contrast, GPR15L, the chemokine ligand of GPR15, failed to inhibit virus infection. We found that Cystatin C fragments preventing GPR15-mediated viral entry do not interfere with GPR15L signaling and are generated by proteases activated at sites of inflammation. The antiretroviral activity of CysC95-146 was confirmed in primary CD4+ T cells and is conserved in simian hosts of SIV infection. Thus, we identified a potent endogenous inhibitor of GPR15-mediated HIV and SIV infection that does not interfere with the physiological function of this G protein-coupled receptor.


2020 ◽  
Author(s):  
Debbie C. Crans ◽  
Duaa Althumairy ◽  
Heide Murakami ◽  
B. George Barisas ◽  
Deborah Roess

Sign in / Sign up

Export Citation Format

Share Document